Introduction
============

Hospital blood banks face the common challenge of maintaining an adequate supply of blood products while minimizing the need to discard expired blood products. To reduce workloads and address the current blood-product wastage of approximately 4%,[@b1-ijgm-12-087] maximum surgical blood-ordering schedule has been adopted as a common standard in elective surgeries.[@b2-ijgm-12-087]--[@b4-ijgm-12-087] This blood-bank policy aims to limit the amount of blood products reserved for some predefined elective surgeries. It aims to balance as closely as possible the number of cross-matched blood units for an operation with the amount actually used in the operating room, thus ensuring that the cross-match:transfusion ratio remains near the industry standard of 2:1.[@b5-ijgm-12-087] Hospitals that have implemented the maximum surgical blood-ordering schedule have reported cost savings and more efficient utilization of blood products.[@b6-ijgm-12-087]

Most head and neck surgeries, including elective thyroid surgeries, have a low cross-match:transfusion ratio,[@b6-ijgm-12-087],[@b7-ijgm-12-087] and previous studies have deemed the risk of blood loss during such surgeries to be too low to necessitate preoperative ordering and reservation of blood units.[@b8-ijgm-12-087] With this study, we aim to determine the risk of blood transfusion during elective thyroid surgery and identify potential factors related to blood loss and transfusion in this setting.

Methods
=======

This retrospective study included all thyroid and parathyroid surgeries performed at King Abdulaziz University Hospital between January 2015 and December 2017. After exclusion patients of incomplete data, 179 patients with complete data who had undergone thyroid surgery were analyzed. Data collected from hospital records for these patients were age, sex, body-mass index, diabetes mellitus status, hypertension status, thyroid-stimulating hormone level, weight of gland, bleeding-disorder status, preoperative hemoglobin level, preoperative prothrombin time, preoperative activated partial thromboplastin time, preoperative international normalized ratio, prior chemotherapy, prior surgery, prior radiotherapy, type of surgery, duration of surgery, estimated blood-loss and blood-transfusion volumes, number of transfused units (if any), and length of postoperative hospital stay. Minimal blood loss is defined as any blood loss of 200 mL or less.

This study received ethical approval prior to data collection. This was attained from the Institutional Review Board of King Abdulaziz University Hospital, Jeddah, Saudi Arabia. Given the nature of our study, consent to review medical records was waived. Patient-data confidentiality was maintained at all times. SPSS version 20 (IBM Corporation, Armonk, NY, USA) was used to analyze data.

Results
=======

Of the 179 patients included in this study, 33 (18.4%) were male. Overall, patients had a mean age and body-mass index of 44.55±13.67 years and 27.66±5.38 kg/m^2^, respectively. The mean duration of surgery was 168.48±90.69 minutes and mean postoperative hospital stay 3.38±1.17 (2--8) days. Mean values and ranges for thyroid-stimulating hormone level, weight, preoperative hemoglobin, prothrombin time, activated partial thromboplastin time, and international normalized ratio are presented in [Table 1](#t1-ijgm-12-087){ref-type="table"}.

A total of 73 patients (40.8%) had a history of prior surgery, while 24 (13.4%) and 36 (20.1%) had diabetes mellitus and hypertension, respectively. None of the patients had a history of previous radiotherapy, bleeding disorder, or blood transfusion ([Table 2](#t2-ijgm-12-087){ref-type="table"}). In a histological review, benign goiter was the most common finding (43.6%), followed by papillary thyroid cancer (27.4%). More than two-thirds of patients (68.7%) underwent total thyroidectomy. During surgery, most patients (76.0%) experienced minimal blood loss during surgery, while only one patient lost 1,500--2,000 mL of blood.

Discussion
==========

Despite reports that routine excessive preoperative blood reservation is a source of economic loss and repeated blood wastage, the practice remains prevalent, particularly in the context of elective thyroid surgeries.[@b2-ijgm-12-087]--[@b4-ijgm-12-087],[@b9-ijgm-12-087],[@b10-ijgm-12-087] Therefore, a clear transfusion policy that minimizes wastage and maximizes utilization is warranted, particularly in low-risk elective surgeries. In this study, we aimed to audit the surgical blood-ordering and -transfusion practices associated with elective thyroid and parathyroid surgeries at our institution. As noted, these practices are intended to balance the availability of blood products with the avoidance of unnecessary wastage.

In our study of patients who underwent elective thyroid and parathyroid surgeries, we found that none required blood transfusion. The reported blood loss was ≤500 mL in the vast majority of patients (98%). High-volume hospitals or those that perform more than four operations daily[@b11-ijgm-12-087] generally report lower rates of mortality and morbidity associated with thyroidectomy compared to hospitals with a lower surgical volume.[@b12-ijgm-12-087],[@b13-ijgm-12-087] None of the included operations in our study was associated with mortality. Additionally, estimated blood loss in most cases was \<30 mL and average operation time \<168 minutes. Two patients that underwent total thyroidectomies for papillary cancer and benign thyroiditis required 1,500 mL and 2,000 mL, but no blood transfusion was required. Only two surgeries had a duration of \>10 hours, and these were for medullary and anaplastic thyroid cancers requiring concomitant neck dissection.

Our results are supported by multiple studies demonstrating a very low risk of blood transfusion during elective thyroid surgery. Kpolugbo et al reported an average blood loss in thyroid surgery of 334.3 mL and found that only 2.5% of the study population of 80 patients required blood transfusion.[@b8-ijgm-12-087] In a review of 1,122 elective thyroid surgeries, Kalenda et al found that only 0.8% of patients required intraoperative blood transfusion. Additionally, the patients requiring transfusion had predisposing factors, including coagulation issues, systemic comorbidities, preoperative anemia, or prolonged operations.[@b14-ijgm-12-087] Weiss et al reported an association of old age with increased morbidity.[@b11-ijgm-12-087]

Patients with large goiters associated with Graves's disease may be an exception to the generally low risk for blood transfusion during thyroid surgery. Yamanouchi et al assessed the risk of blood loss during elective thyroid goiter surgeries, and found a positive correlation between gland weight (\>200 g) and risk of bleeding, which was explained by the potential high vascularity observed in a Graves's disease-associated goiter.[@b15-ijgm-12-087] Interestingly, in our study histopathological analysis showed that 43.6% of excised glands had thyroid goiter; however, no association between this histology and blood-transfusion requirement was found. We note that in our series, the mean thyroid gland weight was 53.4 g, which was lower than that reported by Yamanouchi et al as associated with a requirement for transfusion.

Limitations
===========

Our study has some limitations. First, the analysis was limited by the retrospective nature of the study. A prospective study would better enable an analysis of the potential factors affecting the risk of bleeding during elective surgeries. Second, the study was limited by the lack of specific data, such as the method of discarding unused blood.

Conclusion
==========

This study revealed minimal blood loss and no cases requiring blood transfusion during elective thyroid and parathyroid surgeries. Additionally, we found that comorbidities, thyroid gland size, and coagulation parameters had no effect on the need for blood transfusion. Based on our results and global blood-bank standards, we recommend discontinuing the routine blood cross-matching process in routine thyroid and parathyroid surgeries.
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###### 

Descriptive statistics of all patients (continuous variables, n=179)

                                  Mean     SD       Minimum   Maximum
  ------------------------------- -------- -------- --------- ---------
  Age (years)                     44.55    ±13.67   17.00     78.00
  BMI (mean ± SD)                 27.66    ±5.38    15.26     44.80
  Duration of surgery (minutes)   168.48   ±90.69   50.00     634.00
  Post-op hospital stays (days)   3.38     ±1.17    2.00      8.00
  TSH (mIU/L)                     1.87     ±1.49    0.01      9.65
  Weight of gland (g)             53.44    ±62.80   1.00      480.00
  Pre-op hemoglobin (g/dL)        12.08    ±1.54    7.60      18.70
  PT (seconds)                    11.82    ±1.36    6.12      23.40
  PTT (seconds)                   31.76    ±8.46    23.40     126.30
  INR                             1.02     ±0.13    0.80      2.10

**Abbreviations:** BMI, body-mass index; INR, international normalized ratio; PT, prothrombin; PTT, partial thromboplastin time; TSH, thyroid-stimulating hormone.

###### 

Pathology, type of surgery, and amount of blood loss (n=179)

                                                             n     \%
  ---------------------------------------------------------- ----- -------
                                                                   
  Histopathology                                                   
   Benign goiter                                             78    43.6
   Thyroid cancer/papillary carcinoma                        49    27.4
   Benign thyroid adenoma                                    17    9.5
   Parathyroid adenoma                                       14    7.8
   Parathyroid hyperplasia                                   9     5.0
   Thyroid cancer/follicular carcinoma                       5     2.8
   Benign thyroiditis                                        4     2.2
   Thyroid cancer/medullary carcinoma                        1     0.6
   Tthyroid cancer/poorly differentiated thyroid carcinoma   1     0.6
   Others/low grade (well differentiated) leiomyosarcoma     1     0.6
                                                                   
  Type of surgery                                                  
   Total thyroidectomy                                       123   68.7
   Subtotal thyroidectomy                                    29    16.2
   Total parathyroidectomy                                   15    8.4
   Subtotal parathyroidectomy                                9     5.0
   Radical excision of lymph nodes of neck                   1     0.6
   Excision of thyroid lesion                                1     0.6
   Other procedures on thyroid gland                         1     0.6
                                                                   
  Blood loss                                                       
   Minimal                                                   136   76.0
   Moderate                                                  1     0.6
   30 mL                                                     1     0.6
   100 mL                                                    11    6.1
   150 mL                                                    5     2.8
   200 mL                                                    14    7.8
   250 mL                                                    1     0.6
   300 mL                                                    1     0.6
   400 mL                                                    1     0.6
   500 mL                                                    5     2.8
   700 mL                                                    1     0.6
   1,500 mL                                                  1     0.6
   2,000 mL                                                  1     0.6
                                                                   
  Prior surgery                                                    
   Yes                                                       73    40.8
   No                                                        106   59.2
                                                                   
  Prior radiotherapy                                               
   Yes                                                       0     
   No                                                        179   100.0
                                                                   
  Diabetes mellitus                                                
   Yes                                                       24    13.4
   No                                                        155   86.6
                                                                   
  Hypertension                                                     
   Yes                                                       36    20.1
   No                                                        143   79.9
                                                                   
  Bleeding disorder                                                
   Yes                                                       0     
   No                                                        179   100.0
                                                                   
  Blood transfusion                                                
   Yes                                                       0     
   No                                                        179   100.0
